Contemporary Strategies and Trends in Nursing Care for Women with Breast Cancer

Mónica Patricia Soto-Ayala (), Luis Fernando Taruchain-Pozo (), Carlos Hernán Aguayza-Mendieta (), José Iván Villavicencio-Soledispa () and Jorge Buele ()
Additional contact information
Mónica Patricia Soto-Ayala: Universidad Tecnológica Indoamérica
Luis Fernando Taruchain-Pozo: Universidad Tecnológica Indoamérica
Carlos Hernán Aguayza-Mendieta: Universidad Tecnológica Indoamérica
José Iván Villavicencio-Soledispa: Universidad Tecnológica Indoamérica
Jorge Buele: Universidad Tecnológica Indoamérica

A chapter in Demographic Transitions, Health, and Well-Being, 2025, pp 485-494 from Springer

Abstract: Abstract HER2-positive breast cancer, one of the most aggressive forms of this disease, presents significant therapeutic challenges due to its complexity and high recurrence. Subcutaneous therapies, such as trastuzumab and pertuzumab, have improved treatment efficacy and patient quality of life, but pose challenges for nursing professionals in patient education, prevention of complications, and use of remote monitoring technologies. This study reviewed literature from 2015 to 2024 in databases such as PubMed, Scopus, APA PsycNet, Scielo, and Web of Science to analyze advances in the management of subcutaneous therapies and nursing care. The findings confirm that subcutaneous administration of trastuzumab and pertuzumab is safe and well tolerated, reducing complications compared to traditional methods, especially when using devices such as PICC catheters and subcutaneous ports. The integration of telemedicine and remote monitoring allowed for improved adherence, minimized complications, and optimized resources. Furthermore, ongoing training of nursing staff was identified as essential for effective management of devices and fostering patient autonomy. This review underlines the importance of integrating technologies and education into public health policies to address emerging issues in breast cancer management, especially in vulnerable populations with limited access to services. This review was registered in the Open Science Framework (OSF). (Registration number: DOI: 10.17605/OSF.IO/KWPC9)

Keywords: Breast cancer; HER2-positive; Subcutaneous administration; Nursing care (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:prbchp:978-3-031-94487-1_43

Ordering information: This item can be ordered from
http://www.springer.com/9783031944871

DOI: 10.1007/978-3-031-94487-1_43

Access Statistics for this chapter

More chapters in Springer Proceedings in Business and Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().